Advertisement

Cord blood: the future of regenerative medicine?

Published:December 07, 2009DOI:https://doi.org/10.1016/j.rbmo.2009.10.012

      Abstract

      Cord blood stem cells have been in routine clinical practice for the past 20 years. The development of new therapeutic protocols in regenerative medicine require the use of stem cells and umbilical cord blood is an important and readily available source of cells for these applications. The latest concepts in routine transplantation of cord blood are reviewed followed by the critical role of cord blood stem cells in regenerative medicine research and novel approaches using cord blood as a source of whole blood for transfusion.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Aggarwal S.
        • Pittenger M.F.
        Human mesenchymal stem cells modulate allogeneic immune cell responses.
        Blood. 2005; 105: 1815-1822
        • Amariglio N.
        • Hirshberg A.
        • Scheithauer B.W.
        • et al.
        Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.
        PLoS Med. 2009; 6: e1000029
        • Barker J.N.
        • Weisdorf D.J.
        • DeFor T.E.
        • et al.
        Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
        Blood. 2003; 102: 1915-1919
        • Barker J.N.
        • Weisdorf D.J.
        • DeFor T.E.
        • et al.
        Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
        Blood. 2005; 105: 1343-1347
        • Bhattacharya N.
        Transient spontaneous engraftment of CD34+ hematopoietic cord blood stem cells as seen in peripheral blood: treatment of leprosy patients with anemia by placental umbilical cord whole blood transfusion.
        Clin. Exp. Obstet. Gynecol. 2006; 33: 159-163
        • Bhattacharya N.
        A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anemia and emaciation.
        Clin. Exp. Obstet. Gynecol. 2006; 33: 117-121
        • Bhattacharya N.
        A study of placental umbilical cord whole blood transfusion in 72 patients with anemia and emaciation in the background of cancer.
        Eur. J. Gynaecol. Oncol. 2006; 27: 155-161
        • Borlongan C.V.
        Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
        Stroke. 2009; 40: S146-S148
        • Chaudhuri A.
        • Hollands P.
        • Bhattacharya N.
        Placental umbilical cord blood transfusion in acute ischaemic stroke.
        Med. Hypotheses. 2007; 69: 1267-1271
        • Chen N.
        • Hudson J.E.
        • Walczak P.
        • et al.
        Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural.
        Stem Cells (Dayton, Ohio). 2005; 23: 1560-1570
        • Dimmeler S.
        • Zeiher A.M.
        • Schneider M.D.
        Unchain my heart: the scientific foundations of cardiac repair.
        J. Clin. Invest. 2005; 115: 572-583
        • Djouad F.
        • Plence P.
        • Bony C.
        • et al.
        Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.
        Blood. 2003; 102: 3837-3844
        • Ehring B.
        • Biber K.
        • Upton T.M.
        • et al.
        Expansion of HPCs from cord blood in a novel 3D matrix.
        Cytotherapy. 2003; 5: 490-499
        • Finney M.R.
        • Greco N.J.
        • Haynesworth S.E.
        • et al.
        Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biology of Blood and Marrow Transplantation.
        J. Am. Soc. Blood Marrow Transplant. 2006; 12: 585-593
        • Freed C.R.
        • Greene P.E.
        • Breeze R.E.
        • et al.
        Transplantation of embryonic dopamine neurons for severe Parkinson’s disease.
        N. Engl. J. Med. 2001; 344: 710-719
        • Fuchs J.R.
        • Hannouche D.
        • Terada S.
        • et al.
        Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells.
        Stem Cells (Dayton, Ohio). 2005; 23: 958-964
        • Fukuda H.
        • Masuzaki H.
        • Ishimaru T.
        Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes.
        Int. J. Gynaecol. Obstet. 2002; 77: 123-129
        • Gang E.J.
        • Hong S.H.
        • Jeong J.A.
        • et al.
        In-vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells.
        Biochem. Biophys. Res. Commun. 2004; 321: 102-108
        • Gao F.
        • Wu D.Q.
        • Hu Y.H.
        • et al.
        In-vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells.
        Transl. Res.: J. Lab. Clin. Med. 2008; 151: 293-302
        • Gluckman E.
        • Broxmeyer H.A.
        • Auerbach A.D.
        • et al.
        Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling.
        N. Engl. J. Med. 1989; 321: 1174-1178
        • Hess D.C.
        • Borlongan C.V.
        Cell-based therapy in ischemic stroke.
        Expert Rev. Neurother. 2008; 8: 1193-1201
        • Hollands P.
        Cord blood stem cells – the basic science.
        in: Bhattacharya N. Stubblefield P. Frontiers of Cord Blood Science. Springer-Verlag, London2009: 19-25
        • Hong S.H.
        • Gang E.J.
        • Jeong J.A.
        • et al.
        In-vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.
        Biochem. Biophys. Res. Commun. 2005; 330: 1153-1161
        • Hutson E.L.
        • Boyer S.
        • Genever P.G.
        Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood.
        Tissue Eng. 2005; 11: 1407-1420
        • Ishikawa F.
        • Yasukawa M.
        • Yoshida S.
        • et al.
        Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells.
        FASEB J. 2004; 18: 1958-1960
        • Kakinuma S.
        • Asahina K.
        • Okamura K.
        • et al.
        Human cord blood cells transplanted into chronically damaged liver exhibit similar characteristics to functional hepatocytes.
        Transplant. Proc. 2007; 39: 240-243
        • Kim S.W.
        • Han H.
        • Chae G.T.
        • et al.
        Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger’s disease and ischemic limb disease animal model.
        Stem Cells (Dayton, Ohio). 2006; 24: 1620-1626
        • Krampera M.
        • Pasini A.
        • Pizzolo G.
        • et al.
        Regenerative and immunomodulatory potential of mesenchymal stem cells.
        Curr. Opin. Pharmacol. 2006; 6: 435-441
        • Laughlin M.J.
        • Eapen M.
        • Rubinstein P.
        • et al.
        Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
        N. Engl. J. Med. 2004; 351: 2265-2275
        • Laurencin C.T.
        • Ambrosio A.M.
        • Borden M.D.
        • et al.
        Tissue engineering: orthopedic applications.
        Annu. Rev. Biomed. Eng. 1999; 1: 19-46
        • Le Blanc K.
        • Tammik C.
        • Rosendahl K.
        • et al.
        HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.
        Exp. Hematol. 2003; 31: 890-896
        • Le Blanc K.
        • Tammik L.
        • Sundberg B.
        • et al.
        Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.
        Scand. J. Immunol. 2003; 57: 11-20
        • Lee S.T.
        • Jang J.H.
        • Cheong J.W.
        • et al.
        Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype.
        Br. J. Haematol. 2002; 118: 1128-1131
        • Lee K.D.
        • Kuo T.K.
        • Whang-Peng J.
        • et al.
        In-vitro hepatic differentiation of human mesenchymal stem cells.
        Hepatology. 2004; 40: 1256-1259
        • Lewis I.D.
        • Almeida-Porada G.
        • Du J.
        • et al.
        Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system.
        Blood. 2001; 97: 3441-3449
        • Liu C.H.
        • Hwang S.M.
        Cytokine interactions in mesenchymal stem cells from cord blood.
        Cytokine. 2005; 32: 270-279
        • Loomans C.J.
        • de Koning E.J.
        • Staal F.J.
        • et al.
        Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.
        Diabetes. 2004; 53: 195-199
        • Lu L.L.
        • Liu Y.J.
        • Yang S.G.
        • et al.
        Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
        Haematologica. 2006; 91: 1017-1026
        • McGuckin C.
        • Jurga M.
        • Ali H.
        • et al.
        Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro.
        Nat. Protoc. 2008; 3: 1046-1055
        • McNiece I.
        • Kubegov D.
        • Kerzic P.
        • et al.
        Increased expansion and differentiation of cord blood products using a two-step expansion culture.
        Exp. Hematol. 2000; 28: 1181-1186
        • Murohara T.
        Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors.
        Trends Cardiovasc. Med. 2001; 11: 303-307
        • Nagano M.
        • Yamashita T.
        • Hamada H.
        • et al.
        Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood.
        Blood. 2007; 110: 151-160
        • Naruse K.
        • Nakashima E.
        • Hamada Y.
        • et al.
        Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy.
        Diabetes. 2005; 54: 1823-1828
        • Niemeyer P.
        • Seckinger A.
        • Simank H.G.
        • et al.
        Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in-vitro study.
        Der. Orthopade. 2004; 33: 1346-1353
        • Noel D.
        • Gazit D.
        • Bouquet C.
        • et al.
        Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells.
        Stem Cells (Dayton, Ohio). 2004; 22: 74-85
        • Park D.H.
        • Borlongan C.V.
        • Eve D.J.
        • et al.
        The emerging field of cell and tissue engineering.
        Med. Sci. Monit. 2008; 14: RA206-RA220
        • Park D.H.
        • Borlongan C.V.
        • Willing A.E.
        • et al.
        Human umbilical cord blood cell grafts for stroke.
        Cell Transplant. 2009; (pii: CT-2067 [e-publication ahead of print])
        • Peled T.
        • Mandel J.
        • Goudsmid R.N.
        • et al.
        Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
        Cytotherapy. 2004; 6: 344-355
        • Rocha V.
        • Labopin M.
        • Sanz G.
        • et al.
        Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
        N. Engl. J. Med. 2004; 351: 2276-2285
        • Sanberg P.R.
        • Willing A.E.
        • Garbuzova-Davis S.
        • et al.
        Umbilical cord blood-derived stem cells and brain repair.
        Ann. N. Y. Acad. Sci. 2005; 1049: 67-83
        • Schmidt D.
        • Breymann C.
        • Weber A.
        • et al.
        Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
        Ann. Thorac. Surg. 2004; 78: 2094-2098
        • Shin J.W.
        • Lee D.W.
        • Kim M.J.
        • et al.
        Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion.
        Yonsei Med. J. 2005; 46: 260-267
        • Szabolcs P.
        • Park K.D.
        • Reese M.
        • et al.
        Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood.
        Exp. Hematol. 2003; 31: 708-714
        • Vats A.
        • Tolley N.S.
        • Polak J.M.
        • et al.
        Stem cells: sources and applications.
        Clin. Otolaryngol. Allied Sci. 2002; 27: 227-232
        • Vendrame M.
        • Gemma C.
        • de Mesquita D.
        • et al.
        Anti-inflammatory effects of human cord blood cells in a rat model of stroke.
        Stem Cells Dev. 2005; 14: 595-604
        • Ye Z.Q.
        • Burkholder J.K.
        • Qiu P.
        • et al.
        Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth.
        Proc. Natl Acad. Sci. USA. 1994; 91: 12140-12144
        • Yoshida S.
        • Ishikawa F.
        • Kawano N.
        • et al.
        Human cord blood-derived cells generate insulin-producing cells in vivo.
        Stem Cells (Dayton, Ohio). 2005; 23: 1409-1416
        • Yu G.
        • Borlongan C.V.
        • Stahl C.E.
        • et al.
        Systemic delivery of umbilical cord blood cells for stroke therapy: a review.
        Restor. Neurol. Neurosci. 2009; 27: 41-54
        • Yu Y.
        • Ren H.
        • Yun W.
        • et al.
        Differentiation of human umbilical cord blood-derived mesenchymal stem cells into chondroblast and osteoblasts.
        Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008; 25: 1385-1389
        • Zhao R.C.
        • Liao L.
        • Han Q.
        Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy.
        J. Lab. Clin. Med. 2004; 143: 284-291